FDA Inspection
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. – FDA Inspection, Apr 11, 2025
Record Details
This FDA Inspection record concerns Evonik Rexim (Nanning) Pharmaceutical Co. Ltd., with an inspection on April 11, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9f860ea2-93f5-43b3-9e73-8525d6950d86
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1269495
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.